{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T11:12:03Z","timestamp":1772709123282,"version":"3.50.1"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.2169\/internalmedicine.3722-19","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T22:04:37Z","timestamp":1573164277000},"page":"715-719","source":"Crossref","is-referenced-by-count":6,"title":["Thrombotic Thrombocytopenic Purpura Treated with Rituximab Associated with Primary Sj\u00f6gren's Syndrome and Primary Hypothyroidism"],"prefix":"10.2169","volume":"59","author":[{"given":"Taiki","family":"Okumura","sequence":"first","affiliation":[{"name":"Department of Nephrology, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Aomura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihumi","family":"Kurasawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuta","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoe","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Sonoda","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kamijo","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shinshu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Moake JL. Thrombotic microangiopathies. N Engl J Med 347: 589-600, 2002.","DOI":"10.1056\/NEJMra020528"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Matsumoto M, Fujimura Y, Wada H, et al. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan. Int J Hematol 106: 3-15, 2017.","DOI":"10.1007\/s12185-017-2264-7"},{"key":"3","unstructured":"3. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sj\u00f6gren's syndrome (1999): availability and validity. ModRheumatol 14: 425-434, 2004."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Verbeke L, Delforge M, Dierickx D. Current insight into thrombotic thrombocytopenic purpura. Blood Coagul Fibrinolysis 21: 3-10, 2010.","DOI":"10.1097\/MBC.0b013e32833335eb"},{"key":"5","unstructured":"5. Fujimura Y, Matsumoto M. Registry of 919 Patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008. Intern Med 49: 7-15, 2010."},{"key":"6","unstructured":"6. Yamashita H, Takahashi Y, Kaneko H, Kano T, Mimori A. Thrombotic thrombocytopenic purpura with an autoantibody to ADAMTS13 complicating Sj\u00f6gren's syndrome: two cases and a literature review. Mod Rheumatol 23: 365-373, 2013."},{"key":"7","unstructured":"7. Xu X, Zhu T, Wu D, Zhang L. Sj\u00f6gren's syndrome initially presented as thrombotic thrombocytopenic purpura in a male patient: a case report and literature review. Clin Rheumatol 37: 1421-1426, 2018."},{"key":"8","unstructured":"8. Toumeh A, Josh N, Narwal R, Assaly R. Refractory thrombotic thrombocytopenic purpura associated with primary Sj\u00f6gren syndrome treated with rituximab: a case report. Am J Ther 21: e56-e60, 2014."},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Roriz M, Landais M, Desprez J, et al. Risk factors for autoimmune diseases development after thrombotic thrombocytopenic purpura. Medicine 94: e1598, 2015.","DOI":"10.1097\/MD.0000000000001598"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Jonsson R, Theander E, Sjostrom B, et al. Autoantibodies present before symptom onset in primary Sj\u00f6gren syndrome. JAMA 310: 1854-1855, 2013.","DOI":"10.1001\/jama.2013.278448"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 325: 393-397, 1991.","DOI":"10.1056\/NEJM199108083250604"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Scully M, McDonald V, Cavenagh J, et al. A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura. Blood 118: 1746-1753, 2011.","DOI":"10.1182\/blood-2011-03-341131"},{"key":"13","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1111\/j.1537-2995.2012.03578.x","volume":"52","author":"A Froissart","year":"2012","unstructured":"13. Froissart A, Buffet M, Veyradier A, et al. Efficacy and safety of first-line rituximab in severe, acquired response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center experience. Transfusion 52: 2436-2444, 2012.","journal-title":"Transfusion","ISSN":"https:\/\/id.crossref.org\/issn\/0041-1132","issn-type":"print"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Isonishi A, Bennett CL, Plaimauer B, et al. Poor responder to plasma exchange therapy in acquired with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma. Transfusion 55: 2321-2330, 2015.","DOI":"10.1111\/trf.13182"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Coppo P, Wolf M, Veyradier A, et al. Prognostic value of inhibitory anti ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura. Br J Haematol 132: 66-74, 2005.","DOI":"10.1111\/j.1365-2141.2005.05837.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Psianou K, Panagoulias I, Papanastasiou AD, et al. Clinical and immunological parameters of Sj\u00f6gren's syndrome. Autoimmun Rev 17: 1053-1064, 2018.","DOI":"10.1016\/j.autrev.2018.05.005"},{"key":"17","unstructured":"17. Elliotto MA, Heit JA, Pruthi RK, Gastineau DA, Winters JL, Hook CC. Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated sever ADAMTS13 deficiency: a report of four cases and a systematic review of the literature. Eur J Haematol 83: 364-372, 2009."},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Caramazza D, Quintini G, Abbene I, et al. Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab. Transfusion 50: 2753-2760, 2010.","DOI":"10.1111\/j.1537-2995.2010.02763.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/5\/59_3722-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T03:21:08Z","timestamp":1583551268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/5\/59_3722-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3722-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}